511541-62-1

Usage

General Description

2-Amino-3-bromo-6-hydroxypyridine is a chemical compound with the molecular formula C5H5BrN2O. It is a member of the pyridine family of compounds and is classified as an organic compound. This chemical is a white to off-white solid and is primarily used in the synthesis of pharmaceutical compounds, as well as in other industrial applications. It is also used as a building block in the preparation of various heterocyclic compounds and is known for its potential pharmacological properties. Additionally, 2-Amino-3-bromo-6-hydroxypyridine is considered to have low toxicity and is not known to be harmful to the environment, making it a versatile and relatively safe chemical for various applications.

Upstream product

• 5154-00-7 6-aminopyridine-2(1H)-one 
• 5154-00-7 6-amino-pyridin-2-ol 

Downstream Products

• 511541-63-2 3-bromo-6-methoxypyridin-2-amine 
• 511541-68-7 6-Methoxy-3-(3-methoxy-phenyl)-pyridin-2-yl-amine 
• 511541-66-5 3-(4-fluoro-phenyl)-6-methoxy-pyridin-2-yl-amine 
• 511541-65-4 3-(3-Fluoro-phenyl)-6-methoxy-pyridin-2-yl-amine 
• 511541-67-6 3-(4-chloro-phenyl)-6-methoxy-pyridin-2-yl-amine 
• 1304073-48-0 (2R,3S,5R)-5-(6-(dimethylaminomethyleneamino)-2(1H)-pyridinon-5-ylethynyl)-2-(4,4'-dimethoxytrityloxymethyl)-3-hydroxytetrahydrofuran 
• 1304073-50-4 C₃₉H₄₅N₃O₆Si 

Relevant academic research and scientific papers

RIP1K INHIBITORS

Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceut

DIHYDROPYRIDONE UREAS AS P2X7 MODULATORS

Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein m, n, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with the P2X7 purinergic receptor.

TRIAZOLOPYRIDINES AS PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF DERMAL DISEASES

The present invention relates to a compound according to formula I, wherein R1, R2 and A are as defined herein, which exhibit PDE4 inhibitory activity and may be used in the treatment of inflammatory diseases or autoimmune diseases,

Synthesis of micrococcinic acid

The first synthesis of micrococcinic acid (2) is described. The five rings of 2 are assembled from monocyclic precursors using four palladium-catalyzed biaryl coupling reactions.